Zacks: Analysts Anticipate Apollo Medical Holdings Inc (NASDAQ:AMEH) to Post $0.20 EPS
Brokerages expect Apollo Medical Holdings Inc (NASDAQ:AMEH) to report $0.20 earnings per share for the current quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Apollo Medical’s earnings. Apollo Medical reported earnings of ($0.08) per share during the same quarter last year, which would indicate a positive year over year growth rate of 350%. The company is expected to report its next quarterly earnings report on Monday, March 16th.
On average, analysts expect that Apollo Medical will report full year earnings of $0.40 per share for the current financial year. For the next year, analysts expect that the business will post earnings of $1.27 per share. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research analysts that follow Apollo Medical.
Apollo Medical (NASDAQ:AMEH) last posted its earnings results on Thursday, November 7th. The company reported $0.14 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.14. The business had revenue of $156.06 million during the quarter. Apollo Medical had a return on equity of 3.16% and a net margin of 0.88%.
AMEH traded up $0.41 on Tuesday, hitting $17.92. 64,114 shares of the company traded hands, compared to its average volume of 66,804. The company has a 50 day moving average of $18.25 and a 200-day moving average of $16.96. The company has a quick ratio of 3.05, a current ratio of 3.05 and a debt-to-equity ratio of 1.28. The stock has a market capitalization of $625.28 million, a PE ratio of 61.79, a PEG ratio of 2.74 and a beta of -0.86. Apollo Medical has a 12-month low of $13.02 and a 12-month high of $23.26.
In other news, major shareholder Physicians Of Californi Allied purchased 38,600 shares of the stock in a transaction that occurred on Monday, December 9th. The shares were acquired at an average price of $16.83 per share, for a total transaction of $649,638.00. Also, CEO Thomas S. Lam purchased 10,000 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was purchased at an average price of $16.30 per share, for a total transaction of $163,000.00. In the last 90 days, insiders purchased 303,058 shares of company stock worth $5,428,152. Insiders own 11.83% of the company’s stock.
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Rhumbline Advisers acquired a new stake in shares of Apollo Medical in the 3rd quarter worth approximately $526,000. State Street Corp grew its holdings in shares of Apollo Medical by 189.8% in the 3rd quarter. State Street Corp now owns 498,197 shares of the company’s stock worth $8,778,000 after acquiring an additional 326,304 shares during the period. California State Teachers Retirement System grew its holdings in shares of Apollo Medical by 338.8% in the 3rd quarter. California State Teachers Retirement System now owns 42,628 shares of the company’s stock worth $751,000 after acquiring an additional 32,913 shares during the period. Barclays PLC grew its holdings in shares of Apollo Medical by 238.7% in the 3rd quarter. Barclays PLC now owns 13,790 shares of the company’s stock worth $243,000 after acquiring an additional 9,719 shares during the period. Finally, Commonwealth Equity Services LLC acquired a new stake in shares of Apollo Medical in the 3rd quarter worth approximately $387,000. Institutional investors and hedge funds own 15.96% of the company’s stock.
Apollo Medical Company Profile
Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
Featured Story: Understanding the different types of bonds
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.